Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: zebraspot who wrote (564)	5/4/1998 6:51:00 PM
From: epicure	Respond to of 2135

And as Barnum used to say.... Yeah it is a great STORY. But it is all sizzle at this point, and the sizzle has been oversold. The market won't wait 3-5 years while this thing goes through all the clinicals.

To: zebraspot who wrote (564)	5/4/1998 6:52:00 PM
From: Les H	Respond to of 2135

It went from 83 to 51 today. Not 12 to 51.

To: zebraspot who wrote (564)	5/4/1998 6:56:00 PM
From: Cosmo Daisey	Respond to of 2135

Dr. zebraspot, I agree. This technology is cutting edge with all the researchers lining up to say they have never seen any treatment with this much promise. The CEO has to be restrained in his statements but the bottom line is the stock price is closer to fair value now. The feds are trying to speed the trials up because the results are so promising. Perhaps we will look back someday and think about how cheap the price is today. Dr. Daisey

To: zebraspot who wrote (564)	5/4/1998 7:16:00 PM
From: Tech Master	Respond to of 2135

zs- >>>Hey, if it's going to $5000 a share, will you care if you paid $51 or $41? <<< That is quite a statement.... I think that you will be able to buy this stock in the 20's very shortly. Just think.... you sell tomorrow and buy back in a few days for what will essentially be free.... then go for a ride.... But why be long on a hot air ride that is coming down? You sound like you are long at 80..... Tech Master

To: zebraspot who wrote (564)	5/4/1998 7:48:00 PM
From: Nero	Read Replies (1) \| Respond to of 2135

With you Zebra. Yes, the fundamentals of ENMD have not changed. Yes, clinical trials haven't even begun. Yes, many ''cures'' never make it to market. But . . . What has changed is the public's perception of ENMD's products. The NYT on Sunday made the cancer-curing mechanisms clear to the layman. What even I can understand is that the curative mechanics at work seem likely to withstand the physiological differences between mice and humans. This isn't the latest internet search engine or even a new drug to allow erections . . . this is a lifeline for tens of millions of people. Tough to put a price on. Very difficult to say this germ of an idea tested successfully on small mammals is not worth $100 a share. No, this ain't KTEL folks. Sure the investing risks are large, but the potential rewards are huge. Put a price on life? I'm in at $58.